000 01160 a2200313 4500
005 20250514210944.0
264 0 _c20050314
008 200503s 0 0 eng d
022 _a1057-9230
024 7 _a10.1002/hec.960
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPuliyel, Jacob M
245 0 0 _aPolicy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
_h[electronic resource]
260 _bHealth economics
_cNov 2004
300 _a1147; author reply 1147-8 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aFemale
650 0 4 _aHepatitis B
_xepidemiology
650 0 4 _aHepatitis B Vaccines
_xeconomics
650 0 4 _aHumans
650 0 4 _aImmunization Programs
_xeconomics
650 0 4 _aIndia
_xepidemiology
650 0 4 _aInternet
650 0 4 _aMale
650 0 4 _aModels, Econometric
650 0 4 _aWorld Health Organization
773 0 _tHealth economics
_gvol. 13
_gno. 11
_gp. 1147; author reply 1147-8
856 4 0 _uhttps://doi.org/10.1002/hec.960
_zAvailable from publisher's website
999 _c15234374
_d15234374